[18F]meta-fluorobenzylguanidine

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug Name[18F]meta-fluorobenzylguanidine
Drug Alias Name18F-MFBG
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsHeart FailureCardiomyopathiesCardiovascular Diseases +[9
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGround Fluor Pharmaceuticals
China Registration ClassN/A

Develop Information

Active IndicationsHeart FailureCardiomyopathiesParkinson Disease +[5
Inactive IndicationsCardiovascular DiseasesPheochromocytomaParaganglioma +[4

Other Information

ATC CodeN/A
Related LinksN/A